The home of the Audio Journal of Oncology

Chronic Lymphocytic Leukemia After Fludarabine Failure

AudioMedica News
AudioMedica News
Chronic Lymphocytic Leukemia After Fludarabine Failure
Chronic Lymphocytic Leukemia After Fludarabine Failure
/
John Gribben
John Gribben

Reporting From: 4th European Congress on Hematologic Malignancies, Paris 22-24 February, 2008
JOHN GRIBBEN, Bartholemews Hospital, London
New promise for treating chronic lymphocytic leukemia is arising from combining antibody therapies rituximab and alemtuzumab with new drugs such as lenalidomide alongside standard fludarabine therapy. At the Paris symposium John Gribben gave Peter Goodwin the latest details.

Chronic Lymphocytic Leukemia After Fludarabine Failure



LISTEN

[audio:https://www.audiomedica.com/podcasting/oncology/080227_john_gribben.mp3]

Further reading

Sign up for AudioMedica.com news

* = required field
Speciality